Active Pregnancy Against COVID-19 (ACPREGCOV)
Active Pregnancy, Prevention Against the Effects of COVID-19
Sponsor: Clínica Zuatzu de San Sebastián
Listed as NCT04563065, this NA trial focuses on Fetal Growth Retardation and Fetus Disorder and remains ongoing. Sponsored by Clínica Zuatzu de San Sebastián, it has been updated 9 times since 2020, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
9 versions recorded-
Jun 2025 — Present [monthly]
Unknown NA
-
Sep 2024 — Jun 2025 [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Recruiting → Unknown
-
Sep 2022 — Jul 2024 [monthly]
Recruiting NA
-
Jul 2022 — Sep 2022 [monthly]
Recruiting NA
▶ Show 4 earlier versions
-
Sep 2021 — Jul 2022 [monthly]
Recruiting NA
-
May 2021 — Sep 2021 [monthly]
Recruiting NA
-
Jan 2021 — May 2021 [monthly]
Recruiting NA
-
Oct 2020 — Jan 2021 [monthly]
Recruiting NA
First recorded
Aug 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Clínica Zuatzu de San Sebastián
- Hospital Severo Ochoa
- Hospital Universitario de Torrejón,Madrid
- Hospital Vall d'Hebron
- Puerta de Hierro University Hospital
- Universidad Politecnica de Madrid
For direct contact, visit the study record on ClinicalTrials.gov .